How celiac disease damages the small intestine, step by step
Short answer
Celiac disease almost always occurs in people with the DQ2 or DQ8 gene variants, and NIDDK says gluten triggers the abnormal immune system response that causes the disease1, 2. In short, the chain runs like this:
- Part of gluten is not fully digested, and the leftover peptides can reach the tissue beneath the gut lining3, 4.
- An enzyme, tissue transglutaminase, chemically changes some of those peptides, which enhances the way they stimulate T cells5, 6.
- Immune cells carrying DQ2 or DQ8 show the changed peptides to T cells7, 8.
- The inflammation that follows kills lining cells, enlarges the crypts and blunts the villi9.
- With the villi damaged, the intestine is less able to absorb nutrients10, 11.
Part of Gut science, healing and treatment research, 11 guides

Key points
- Almost everyone with celiac disease has the genes, but most people with the genes never develop it: NIDDK says about 30 percent of people have DQ2 or DQ8, and only about 3 percent of them develop celiac disease1.
- Gluten is unusual because parts of it resist digestion, and the peptides left over can trigger immune responses12, 13.
- The antibodies in a blood test and the changes in a biopsy are two traces of one process: antibodies against tissue transglutaminase come from B cells that T helper cells activate, and villous blunting comes from the inflammation14, 9.
- The two traces are not interchangeable in follow-up: the BMC Medicine review says strict adherence to a gluten-free diet in most patients leads to a fall or disappearance of antibodies within 12 months, but that the disappearance of anti-tTG antibodies does not reflect regrowth of the villi15, 16.
- What else raises the chance in people with the genes is still being studied: NIDDK says researchers are studying other factors that may increase a person’s chances17.
Two conditions have to be met: the genes and gluten
NIDDK says celiac disease almost always occurs in people who have one of two groups of gene variants, DQ2 and DQ8, and that people without them are very unlikely to develop it1. Gluten is the trigger: NIDDK says eating it sets off the abnormal immune response that causes the disease2.
Having the genes is common, and having the disease is not. NIDDK puts the share of people with DQ2 or DQ8 at about 30 percent, and the share of those who develop celiac disease at about 3 percent1. The BMC Medicine review gives its own range, 25 to 35 percent, and the same 3 percent18. It adds that genome-wide studies have linked more than 100 other genes to celiac disease19, though the relevance of those genes to genetic risk is, in its words, rather limited20.
Why part of gluten gets past digestion
NIDDK describes gluten as a protein found naturally in wheat, barley and rye, common in foods such as bread, pasta, cookies and cakes21. For how we read some of those foods, see our verdicts on wheat flour, bread, barley and malt extract.
The BMC Medicine review says gliadins, key components of gluten, are unusually rich in prolines and glutamines and are not completely digestible by intestinal enzymes3. It describes gluten as one of the few digestion-resistant proteins eaten chronically in significant quantities12, and says the mix of peptides left by partial digestion can trigger responses that resemble those provoked by potentially harmful microorganisms13.
The steps from gluten to inflammation, in order
The BMC Medicine review lays the process out as a numbered figure22. These are its main steps in plain words, in its order.
- Gliadin loosens the seal between lining cells. The review’s authors report that gliadin can cause an immediate, temporary increase in the permeability of the tight junctions between cells of the gut lining23, an effect they link to the release of a family of molecules called zonulin24.
- Gluten peptides reach the tissue beneath the lining. The figure says functional loss of the gut barrier facilitates the movement of gliadin peptides from the lumen, the inside of the gut, to the lamina propria, the layer under the lining4.
- The innate immune system raises the alarm. The review says innate immunity plays a critical role in initiating celiac disease, with signals such as interleukin-15 priming the response25.
- An enzyme modifies the peptides. The figure has tissue transglutaminase, released from lining cells that die in this innate response, partially deamidating gliadin peptides5. The background line of a trial abstract states the consequence: deamidation of glutamine residues in gluten peptides enhances stimulation of T cells and leads to mucosal injury6.
- Immune cells carrying DQ2 or DQ8 show the changed peptides to T cells. The figure says deamidated gliadin is recognized by DQ2/8-positive antigen-presenting cells7. The review says the interplay between selected gluten peptides and HLA-DQ2/8-restricted T cells plays a paramount role in celiac disease8. This is the step where the gene variants from the first section matter.
- T helper cells activate B cells, which make antibodies against the enzyme. The figure has T helper cells triggering B cells to produce IgM, IgG and IgA antibodies against tissue transglutaminase14. Antibodies against it are among the blood tests the review lists for diagnosis26.
- Inflammation wears down the lining. The review says contact between CD4+ T cells in the lamina propria and gluten activates them, with inflammatory signals and growth factor produced by stromal cells; this induces crypt hyperplasia (enlarged crypts) and villous blunting, secondary to the death of lining cells that intraepithelial lymphocytes induce9.
What the villi do and how a biopsy grades the damage
Coeliac UK describes the lining of the gut that the immune system attacks as the villi, the place where food and nutrients are absorbed10. NIDDK says the walls of the small intestine absorb water and digested nutrients into the bloodstream27. The small intestine’s first part is the duodenum28, and the review’s biopsy recommendation names it: four biopsies on the second duodenal portion and two at the bulb29.
A pathologist grades what the biopsy shows. In the Marsh–Oberhüber scale the review describes, the typical celiac lesion is villous atrophy, with a villi-to-crypt ratio the review gives as under 3:1 down to 1:1, plus more intraepithelial lymphocytes (IELs)30.
| Grade | What the pathologist sees | What the review says about it |
|---|---|---|
| Types 1 and 2 | More IELs, with or without enlarged crypts, and normal villi31 | Compatible with celiac disease but not specific to it31 |
| Type 3 | Villous atrophy, a changed villi-to-crypt ratio and more IELs30 | The typical celiac lesion30 |
| Types 3a, 3b and 3c | Mild, partial and subtotal atrophy30 | Subdivisions of type 3 by the severity of the atrophy30 |
An abnormal biopsy and a positive antibody test do not always go together. The review says the potential form of celiac disease is characterized by positive serological and genetic markers with a normal intestinal mucosa and minimal signs of inflammation32. It also says minimal lesions are in most cases attributable to other causes33.
Why damaged villi show up as nutrient, bone and blood problems
NIDDK says celiac disease can keep the body from getting all the nutrients it needs34, and its research summary says the autoimmune reaction damages the small intestine and interferes with the intestine’s ability to absorb nutrients11.
The long-term complications NIDDK lists include accelerated osteoporosis or bone softening, anemia and malnutrition35. For children, NIDDK says that being unable to absorb nutrients at a time when they matter for normal growth and development can lead to a list of problems that includes slowed growth and short height36.
Iron shows how place and problem line up. A 2021 review says nearly all absorption of dietary iron occurs in the duodenum37, the part of the small intestine the BMC Medicine review says is biopsied29. The BMC Medicine review lists iron deficiency anemia among the signs of celiac disease, detectable in up to 40 percent of cases, and attributes it to iron malabsorption or chronic inflammation38. It also reports bone density changes, osteopenia or osteoporosis, in about 70 percent of patients at diagnosis, related to altered absorption of calcium and vitamin D339.
Which test shows which step
NIDDK says doctors most often use blood tests and biopsies of the small intestine to diagnose or rule out celiac disease40. Each looks at a different trace of the chain above; the table matches them to the numbered steps.
| Test | Which step it reflects | What the sources say |
|---|---|---|
| Genetic test for DQ2 and DQ8 | The starting condition: the gene variants in step 5 | NIDDK: without the variants celiac disease is very unlikely41; having DQ2 or DQ8 alone does not mean a person has celiac disease42 |
| Blood antibody tests (anti-tTG, EmA, DGP) | Step 6, the antibody response against tissue transglutaminase; DGP antibodies are named for the deamidated gliadin peptides of step 426, 43 | NIDDK: certain antibody levels are often higher than normal in people with untreated celiac disease44. ACG: detecting celiac-specific antibodies, for example tissue transglutaminase, is very helpful for initial screening of people suspected of celiac disease45 |
| Duodenal biopsy | Step 7, the injury itself: villous blunting and atrophy, with more IELs30 | NIDDK: a pathologist examines the tissue under a microscope for signs of celiac disease46. ACG: biopsy is required in most patients to confirm the diagnosis47 |
A 2021 review in Gastroenterology says that in adults, diagnosis still depends on duodenal villous atrophy while the person is on a gluten-containing diet, together with serology findings48. The same review notes that some children are diagnosed without a biopsy, although guidelines in the United States continue to mandate a biopsy at all ages49.
NIDDK says doctors do not recommend starting a gluten-free diet before diagnostic testing, because the diet can affect test results50. The review’s account of recovery fits that: it says strict compliance with a gluten-free diet in most patients leads to the disappearance or significant decrease of antibodies within 12 months (18–24 months if the antibody titer is very high), together with regrowth of the villi15.
The review does not treat the two traces as interchangeable in follow-up. It says IgA anti-tTG antibodies are the most commonly used test for follow-up, although their disappearance does not reflect the regrowth of villi16, and, in discussing follow-up biopsies in adults, that the average time for the villi to be fully restored could take up to 3 years51. NIDDK says a gluten-free diet can relieve symptoms and heal damage to the small intestine52.
Neither trace is perfect. The review says a small number of people with celiac disease, around 2–3 percent, test negative for serological markers53, and, as above, some people with positive antibodies and gene markers have a normal mucosa or only minimal inflammation32.
What researchers have not settled
- Why most people with the genes never develop it. NIDDK says researchers are studying other factors17, and that experts think changes in the microbiome could play a role54. The BMC Medicine review cautions that studies linking celiac disease to microbiome changes are associative and do not necessarily imply causation55.
- Why diagnoses have risen. A 2021 review in Gastroenterology says the reasons for the true rise in recent decades are unknown, though possibly related to environmental factors that may promote loss of tolerance to dietary gluten56.
- Whether the T cell attack explains the whole disease. The BMC Medicine review’s authors say the lack of consistent celiac-like intestinal damage in humanized mice57 supports the concept that the T cell attack on lining cells cannot fully explain the disease58, and supports the notion that an intrinsic defect of the stem cell compartment in people at risk is a key element of the enteropathy59.
- How to model the disease. The 2019 review calls the lack of a reliable, reproducible animal model a major drawback in celiac research60. In 2020 NIDDK reported on a mouse model engineered to resemble people with the disease, who have high levels of interleukin-15 in the small intestine61; the mice developed intestinal damage after eating gluten for 30 days, and it reversed when gluten stopped62.
- Treatments aimed at a step in the chain. A trial report says inhibition of transglutaminase 2, the enzyme in step 4, is a potential treatment63. Its primary end point was the attenuation of gluten-induced mucosal damage, measured as the ratio of villus height to crypt depth64, and its preliminary result was that treatment with ZED1227 attenuated gluten-induced duodenal mucosal damage65.
Verdicts in this guide
Questions people ask
Is celiac disease the same as a wheat allergy or gluten sensitivity?
No, according to NIDDK. Wheat allergies do not cause long-term damage to the small intestine66, and gluten sensitivity does not damage the small intestine67.
Can celiac disease cause problems without symptoms?
NIDDK says people with celiac disease who have no symptoms can still develop complications over time if they do not get treatment68.
More in Gut science, healing and treatment research
What gluten does in the gut: celiac disease, wheat allergy and gluten sensitivity comparedHow celiac disease, wheat allergy and non-celiac gluten sensitivity differ in the gut, and why testing comes before cutting out gluten.
Can someone with celiac disease eat gluten again?What NIDDK, the ACG guideline and studies say about eating gluten again with celiac disease, why feeling well is not healing, and who runs a challenge.
How long celiac healing takes: symptoms, antibodies and the gut liningWhat studies report on how long symptoms, blood antibodies and the intestinal lining take to recover on a gluten-free diet, and what to ask your care team.
How much gluten causes damage: what dose studies show and what 20 ppm meansWhat dose studies in celiac disease measured, how 20 ppm converts to milligrams for a real portion, and what FDA’s limit is and is not.
Leaky gut and gluten: what the studies measured, and in whomIs “gluten causes leaky gut” true? Sort the claims by evidence: cell and biopsy studies, trials in people, zonulin tests, and what to ask a test seller.
What happens when you stop eating gluten, condition by conditionWhat a gluten-free diet does in celiac disease, dermatitis herpetiformis, wheat allergy, gluten sensitivity and with no diagnosis, with the trials.
All 11 guides in Gut science, healing and treatment research
Related guides
Celiac Blood Tests: What tTG-IgA, Total IgA, DGP and EMA Each CheckWhat tTG-IgA, total IgA, EMA and DGP check, why total IgA is drawn with tTG-IgA, when back-up tests are used, and why gluten stays in the diet first.
Celiac genetic testing: what HLA-DQ2 and DQ8 results can and cannot tell youWhat HLA-DQ2 and DQ8 typing checks for, how NIDDK, ACG, ESPGHAN and WGO read a negative or positive result, and where the guidelines place the test.
Celiac disease drugs in clinical trials: what each record showsWhat the trial records and published papers show for celiac disease drug candidates, dated, and how to read a phase, a gluten challenge or a headline.
Starting a gluten-free diet: testing first, then labels, oats and the kitchenWhat NIH and the celiac charities say about starting a gluten-free diet: testing first, which foods to start with, a US label check, oats and the kitchen.
Sources
- [1, 2, 17, 36, 54, 68] National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Symptoms & Causes of Celiac Disease, checked Nov 17, 2026.
Read on 2026-11-17: the sentence “For children with celiac disease, being unable to absorb nutrients at a time when they are so important to normal growth and development can lead to” is followed by a list that names damage to the permanent teeth’s enamel, delayed puberty, failure to thrive, mood changes or feeling annoyed or impatient, slowed growth and short height, and weight loss.
- [3, 4, 5, 7, 8, 9, 12, 13, 14, 15, 16, 18, 19, 20, 22, 23, 24, 25, 26, 29, 30, 31, 32, 33, 38, 39, 43, 51, 53, 55, 57, 58, 59, 60, 69] BMC Medicine (Caio et al., 2019), via PubMed Central, Celiac disease: a comprehensive current review, checked Nov 17, 2026.
- [6, 63, 64, 65] New England Journal of Medicine (Schuppan et al., 2021), via PubMed, A Randomized Trial of a Transglutaminase 2 Inhibitor for Celiac Disease, checked Nov 17, 2026.
- [10] Coeliac UK, What Causes Coeliac Disease? Genetics and Risks, checked Nov 17, 2026.
- [11, 61, 62] National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), New Mouse Model Mimics Celiac Disease in People (research update, 2020), checked Nov 17, 2026.
- [21, 34, 35, 66, 67] National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Definition & Facts for Celiac Disease, checked Nov 17, 2026.
Read on 2026-11-17: the list headed “What are the complications of celiac disease?” names, as long-term complications, accelerated osteoporosis or bone softening (osteomalacia), anemia, malnutrition, nervous system problems and problems related to the reproductive system.
- [27, 28] National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Your Digestive System & How it Works, checked Nov 17, 2026.
- [37] Nutrients (2021 review), via PubMed Central, Iron Deficiency in Celiac Disease: Prevalence, Health Impact, and Clinical Management, checked Nov 17, 2026.
- [40, 41, 42, 44, 46, 50] National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Diagnosis of Celiac Disease, checked Nov 17, 2026.
- [45, 47] American Journal of Gastroenterology (ACG guideline, 2023), via PubMed, American College of Gastroenterology Guidelines Update: Diagnosis and Management of Celiac Disease, checked Nov 17, 2026.
- [48, 49, 56] Gastroenterology (Lebwohl & Rubio-Tapia, 2021), via PubMed, Epidemiology, Presentation, and Diagnosis of Celiac Disease, checked Nov 17, 2026.
- [52] National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Eating, Diet, & Nutrition for Celiac Disease, checked Nov 17, 2026.